Literature DB >> 17919659

Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.

Naama Lev1, Yechiel Shai.   

Abstract

Various fusion proteins from eukaryotes and viruses share structural similarities such as a coiled coil motif. However, compared with eukaryotic proteins, a viral fusion protein contains a fusion peptide (FP), which is an N-terminal hydrophobic fragment that is primarily involved in directing fusion via anchoring the protein to the target cell membrane. In various eukaryotic fusion proteins the membrane targeting domain is cysteine-rich and must undergo palmitoylation prior to the fusion process. Here we examined whether fatty acids can replace the FP of human immunodeficiency virus type 1 (HIV-1), thereby discerning between the contributions of the sequence versus hydrophobicity of the FP in the lipid-merging process. For that purpose, we structurally and functionally characterized peptides derived from the N terminus of HIV fusion protein - gp41 in which the FP is lacking or replaced by fatty acids. We found that fatty acid conjugation dramatically enhanced the capability of the peptides to induce lipid mixing and aggregation of zwitterionic phospholipids composing the outer leaflet of eukaryotic cell membranes. The enhanced effect of the acylated peptides on membranes was further supported by real-time atomic force microscopy (AFM) showing nanoscale holes in zwitterionic membranes. Membrane-binding experiments revealed that fatty acid conjugation did not increase the affinity of the peptides to the membrane significantly. Furthermore, all free and acylated peptides exhibited similar alpha-helical structures in solution and in zwitterionic membranes. Interestingly, the fusogenic active conformation of N36 in negatively charged membranes composing the inner leaflet of eukaryotic cells is beta-sheet. Apparently, N-terminal heptad repeat (NHR) can change its conformation as a response to a change in the charge of the membrane head group. Overall, the data suggest an analogy between the eukaryotic cysteine-rich domains and the viral fusion peptide, and mark the hydrophobic nature of FP as an important characteristic for its role in lipid merging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919659     DOI: 10.1016/j.jmb.2007.09.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

Review 1.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

Review 2.  Amphipathic properties of HIV-1 gp41 fusion inhibitors.

Authors:  Miriam Gochin; Guangyan Zhou
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

3.  Cell-cell membrane fusion induced by p15 fusion-associated small transmembrane (FAST) protein requires a novel fusion peptide motif containing a myristoylated polyproline type II helix.

Authors:  Deniz Top; Jolene A Read; Sandra J Dawe; Raymond T Syvitski; Roy Duncan
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

4.  Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations.

Authors:  Kelly Sackett; Matthew J Nethercott; Raquel F Epand; Richard M Epand; Douglas R Kindra; Yechiel Shai; David P Weliky
Journal:  J Mol Biol       Date:  2010-01-18       Impact factor: 5.469

5.  Structural and functional properties of the membranotropic HIV-1 glycoprotein gp41 loop region are modulated by its intrinsic hydrophobic core.

Authors:  Jiayin Qiu; Avraham Ashkenazi; Shuwen Liu; Yechiel Shai
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

6.  Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1.

Authors:  Avraham Ashkenazi; Mathias Viard; Linor Unger; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2012-08-07       Impact factor: 5.191

7.  Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.

Authors:  Hai-bo Qiu; Li-yi Zhang; Chao Ren; Zhao-lei Zeng; Wen-jing Wu; Hui-yan Luo; Zhi-wei Zhou; Rui-hua Xu
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

Review 8.  Biophysical approaches for exploring lipopeptide-lipid interactions.

Authors:  Sathishkumar Munusamy; Renaud Conde; Brandt Bertrand; Carlos Munoz-Garay
Journal:  Biochimie       Date:  2020-01-21       Impact factor: 4.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.